Diagnostic value of exosome-derived lncRNA PITPNA-AS1 in lung cancer

These results reveal that exosome-derived lncRNA PITPNA-AS1 acts as an oncogene to promote malignant biological behaviors and is a promising diagnostic biomarker in lung cancer.

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2025-04-24
DOI
https://doi.org/10.3389/fimmu.2025.1539557
Citations
3
Primary Topic
Cancer-related molecular mechanisms research
Type
article
Field-Weighted Citation Impact
2.81
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Diagnostic value of exosome-derived lncRNA PITPNA-AS1 in lung cancer

Feng Xu, Mujin Chen, ChengChen Liu, Lijuan Su et al.
3 citations
Frontiers in Immunology
Cancer-related molecular mechanisms research
2.81
article

Diagnostic value of exosome-derived lncRNA PITPNA-AS1 in lung cancer

Feng Xu, Mujin Chen, ChengChen Liu, Lijuan Su, Jinfeng Zhu, Xiaofeng Li, Yan Huang
article en
3 citations

Abstract

These results reveal that exosome-derived lncRNA PITPNA-AS1 acts as an oncogene to promote malignant biological behaviors and is a promising diagnostic biomarker in lung cancer.

Frontiers in ImmunologyVol. 16
Fujian Medical University (CN), Ruijin Hospital (CN)
Openalex Percentile: Top 10%
Cancer-related molecular mechanisms research
2.81
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.